Lyell Immunopharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Elizabeth Homans

CEOElizabeth Homans

Employees

190

Employees190

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

190

Employees190

LYEL Key Statistics

Market cap

968.63M

Market cap968.63M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

975.51K

Average volume975.51K

High today

$4.01

High today$4.01

Low today

$3.76

Low today$3.76

Open price

$3.76

Open price$3.76

Volume

911.19K

Volume911.19K

52 Week high

$10.33

52 Week high$10.33

52 Week low

$3.57

52 Week low$3.57

LYEL Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 28, After Hours

ActualExpected Mar 28, After Hours

Lyell Immunopharma

Why Robinhood?

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Show more

LYEL Key Statistics

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.